glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Antibody-drug conjugates: A new twist
Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death RETRACTED ARTICLE: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Scientific Reports Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Oncology Letters
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




